Read “Sanofi’s 2019 Pricing Principles Report,” an update to the Pricing Principles established for 2018 which focuses on three pillars: basing prices on value, limiting price increases, and being transparent…
BRILINTA reduced cardiovascular events in these patients with no prior heart attack or stroke The Phase III THEMIS trial met its primary endpoint which demonstrated that BRILINTA® (ticagrelor) tablets, taken in conjunction…
Washington, D.C., February 22, 2019 – The Association of Black Cardiologists (ABC), Inc., is proud to participate in National Heart Valve Disease Awareness Day on February 22—an annual campaign to…
Don’t shortchange this one life that you have This February 22 is National Heart Valve Disease Awareness Day. As many as 11 million Americans have heart valve disease (HVD), which…
Listen to Your Heart on National Heart Valve Disease Awareness Day This February 22 is National Heart Valve Disease Awareness Day. As many as 11 million Americans have heart…
Comment: “Especially for our high risk patients, clinicians strive to offer the best evidence-based care possible, regardless of race/ethnicity, geography or socioeconomic status. Recent data have shown that alirocumab reduces…
